E2 ModerateModerate confidencePEM unclearCross-SectionalPeer-reviewedMachine draft
Further validation of the Multidimensional Fatigue Inventory in a US adult population sample.
Lin, Jin-Mann S, Brimmer, Dana J, Maloney, Elizabeth M et al. · Population health metrics · 2009 · DOI
Quick Summary
This study tested whether a 20-question fatigue measurement tool (the MFI-20) works well for people with ME/CFS and other chronic illnesses. Researchers gave the questionnaire to 783 people in Georgia—some with ME/CFS-like illness, some with chronic unwellness, and some who were healthy—and found that the tool reliably distinguished between these groups and accurately measured different types of fatigue.
Why It Matters
This is the first rigorous validation of the MFI-20 in ME/CFS and related fatiguing illnesses in a large US population sample. Having a well-validated, reliable fatigue measurement tool is essential for consistent diagnosis, tracking symptom changes over time, and comparing outcomes across ME/CFS research studies and clinical settings.
Observed Findings
- The MFI-20 subscales showed strong inter-item correlations (0.38–0.61) with no redundancy and Cronbach's alpha coefficients of ≥0.70, indicating good internal consistency.
- All three diagnostic groups (CFS-like, chronically unwell, and well) showed significantly different MFI-20 scores, demonstrating the tool's ability to discriminate between conditions.
- The MFI-20 correlated strongly with depression (Zung SDS), anxiety (STAI), and functional impairment (SF-36), validating its measurement of fatigue-related constructs.
- No significant floor or ceiling effects were observed, indicating the questionnaire effectively captured fatigue across the full range of severity.
Inferred Conclusions
- The MFI-20 is a reliable and valid instrument for measuring multidimensional fatigue in chronically unwell and well populations.
- The MFI-20 may serve as a useful complementary diagnostic tool alongside clinical assessment in fatiguing illnesses such as ME/CFS.
- The tool's strong convergent validity suggests it captures clinically meaningful aspects of fatigue related to mood, anxiety, and functional impairment.
Remaining Questions
- Does the MFI-20 sensitivity change over time in response to treatment or natural disease progression in ME/CFS patients?
- Which specific MFI-20 subscales best differentiate ME/CFS from other fatiguing conditions or from psychiatric illness?
What This Study Does Not Prove
This study does not establish that the MFI-20 can diagnose ME/CFS on its own—only that it can complement clinical assessment. The cross-sectional design cannot determine whether fatigue causes the observed mood and anxiety changes or vice versa. The study also does not address whether the MFI-20 is sensitive to changes in fatigue severity within individual patients over time (test-retest reliability).
Tags
Symptom:Fatigue
Method Flag:Weak Case Definition
Metadata
- DOI
- 10.1186/1478-7954-7-18
- PMID
- 20003524
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →